Home » ETF » HELX

HELX - Franklin Genomic Advancements ETF

Stock Price: $45.08 USD -0.52 (-1.15%)
Updated Apr 16, 2021 4:00 PM EDT - Market closed
After-hours: $45.08 0.00 (0.00%) Apr 16, 8:00 PM
Assets $4.56M
NAV $45.59
Expense Ratio 0.50%
PE Ratio n/a
Beta (5Y) -2.37
Dividend (ttm) $0.05
Dividend Yield 0.11%
Ex-Dividend Date Dec 14, 2020
1-Year Return -
Trading Day April 16
Last Price $45.08
Previous Close $45.60
Change ($) -0.52
Change (%) -1.15%
Day's Open 45.89
Day's Range 45.04 - 45.89
Day's Volume 433
52-Week Range 25.09 - 53.47

Fund Description

The investment seeks capital appreciation. Under normal market conditions, the fund invests at least 80% of its net assets in equity securities of companies that are relevant to its investment theme of genomic advancements. The fund invests predominantly in common stock. Although it may invest across economic sectors, the fund concentrates its investments in health care related industries. It is non-diversified.

Asset Class
Equity
Inception Date
Feb 25, 2020
Exchange
BATS
Ticker Symbol
HELX
Index Tracked
Solactive Genomics Index

Top 10 Holdings

42.72% of assets
NameSymbolWeight
Intellia TherapeuticsNTLA6.07%
WUXI BIOLOGICS CAYMAN INC2269.HK5.81%
RepligenRGEN5.05%
NateraNTRA4.64%
IlluminaILMN4.58%
CRISPR TherapeuticsCRSP4.10%
Guardant HealthGH3.22%
10X GenomicsTXG3.17%
Veeva SystemsVEEV3.06%
CatalentCTLT3.02%
View All Holdings

Dividends

Ex-DividendAmountPay Date
Dec 14, 2020$0.00501Jan 1, 1970
Full Dividend History

News

There are no news available yet.